A potential target for experimental drugs that block PRMT5 - a naturally occurring enzyme some tumors rely more on for ...

Enzymes are vital to metabolism and drive countless biological processes in humans, plants, and industry. Yet, when ...

During a live event, Mark Yarchoan, MD, and participants reviewed adverse event management for 3 different combination ...

A potential target for experimental drugs that block PRMT5—a naturally occurring enzyme some tumors rely more on for survival ...

Enzymes are vital to metabolism and drive countless biological processes in humans, plants, and industry. Yet, when ...

Massey Comprehensive Cancer Center is the first U.S. site to enroll patients in a global trial of first-in-class therapy for skin-related T-cell lymphoma -- a rare type of non-Hodgkin lymphoma that ...

Scientists uncover shared genetic signals between chronic dry cough and ACE inhibitor-induced cough, pointing to neurological ...

In a recent paper published in Nature, researchers at the University of Chicago discovered how to block nicotinamide N-methyl ...

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...

New research suggests that COVID-19 can lead to protein build-up similar to that seen in Alzheimer's patients, not just in ...

Experts see tolebrutinib as part of a broader shift toward treatments that target the neurodegeneration in MS, not just its ...

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.